Skip to content

AYALA PHARMACEUTICALS, INC.: filings

Every AYALA PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 52 filings, each linked to its SEC index.

Filing record ends 2024-04-16

The latest filing in this captured record is a 10-K filed 2024-04-16. No later filing is in the SEC companyfacts record captured on 2026-09-22. AYALA PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2024-04-16fiscal FY 202344870001493152-24-014822
10-Q2023-11-20fiscal Q3 202333910001493152-23-041998
10-Q2023-08-10fiscal Q2 202333920001493152-23-027531
10-Q2023-05-23fiscal Q1 202332640001493152-23-018686
10-K2023-02-10fiscal FY 202241860001493152-23-004167
10-Q2022-09-13fiscal Q3 2022401180001493152-22-025666
10-Q2022-06-08fiscal Q2 2022411150001493152-22-016125
10-Q2022-03-17fiscal Q1 202235750001493152-22-007099
10-K2022-02-14fiscal FY 202137790001493152-22-004469
10-Q2021-09-10fiscal Q3 2021371000001493152-21-022350
10-Q2021-06-14fiscal Q2 202139970001493152-21-014308
10-Q2021-03-16fiscal Q1 202134680001493152-21-006062
10-K2021-01-22fiscal FY 202040750001493152-21-001656
10-Q2020-09-10fiscal Q3 202039990001493152-20-017558
10-Q2020-06-11fiscal Q2 2020441170001493152-20-010996
10-Q2020-03-13fiscal Q1 202041760001493152-20-003900
10-K2019-12-20fiscal FY 201942830001493152-19-019523
10-Q2019-09-09fiscal Q3 2019401090001493152-19-013861
10-Q2019-06-10fiscal Q2 2019451240001493152-19-008929
10-Q2019-03-12fiscal Q1 201940830001493152-19-003181
10-K2019-01-11fiscal FY 201836730001493152-19-000489
10-Q2018-09-10fiscal Q3 201836930001493152-18-013055
10-Q2018-06-07fiscal Q2 201836920001493152-18-008309
10-Q2018-03-12fiscal Q1 201832630001493152-18-003234
10-K2017-12-21fiscal FY 201733810001493152-17-014889
10-Q2017-09-11fiscal Q3 201732810001493152-17-010463
10-Q2017-06-06fiscal Q2 201732830001493152-17-006268
10-Q2017-03-10fiscal Q1 201728580001493152-17-002328
10-K2017-01-09fiscal FY 201630750001493152-17-000250
10-Q2016-09-08fiscal Q3 201629730001493152-16-013178
10-Q2016-06-08fiscal Q2 201629730001493152-16-010602
10-Q2016-02-26fiscal Q1 201629550001493152-16-007685
10-K2016-01-08fiscal FY 201529600001493152-16-006703
10-Q2015-09-11fiscal Q3 201528720001493152-15-004310
10-Q2015-06-15fiscal Q2 201527690001493152-15-002480
10-Q2015-03-13fiscal Q1 201528530001493152-15-000831
10-K2015-01-06fiscal FY 201431630001493152-15-000050
10-Q2014-09-09fiscal Q3 201429780001493152-14-002907
10-Q2014-06-10fiscal Q2 201429810001493152-14-001851
10-Q2014-03-17fiscal Q1 201429730001144204-14-016138
10-K2014-01-29fiscal FY 2013341050001144204-14-004716
10-Q2013-09-16fiscal Q3 2013311030001144204-13-050970
10-Q2013-06-14fiscal Q2 2013321040001144204-13-034985
10-Q/A2013-03-25fiscal Q1 201332810001144204-13-017289
10-K/A2013-02-14fiscal FY 201233960001144204-13-009374
10-Q/A2012-10-18fiscal Q1 201227710001144204-12-056846
10-Q/A2012-10-18fiscal Q2 201226890001144204-12-056844
10-Q/A2012-10-04fiscal Q3 2012301070001144204-12-054726
10-Q2012-06-14fiscal Q2 201226890001144204-12-034931
10-Q2012-03-16fiscal Q1 201227710001144204-12-015647
10-K2012-01-26fiscal FY 2011331010001144204-12-004201
10-Q2011-09-12fiscal Q3 2011331080001144204-11-052424

Inspect the source

Entity
AYALA PHARMACEUTICALS, INC. / CIK 0001100397
Captured
SEC response SHA-256
c79571e45bf72206000628dd6d16cc0b78424a189c2c21675f51fe12cd89a549

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001100397.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))